Jon StojanHepatitis C is the most common blood-borne viral infection in the United States, with around 2.4 million people living with the disease. However, many people with the infection do not know that they have it. This is clouded by myths and misunderstandings that hinder early detection and treatment.
The viral infection is often misunderstood and unfairly stigmatized, leading to significant barriers in prevention and diagnosis. One prevalent myth is that Hepatitis C exclusively affects individuals who engage in drug use. While injection drug use remains a serious risk factor, it is far from the only way the virus spreads.
“Many people still believe that Hepatitis C is a disease only associated with drug use,” notes Christine Sewell, Executive Director of HepC Alliance. “In reality, hep C can be transmitted through various means, including sharing personal care items such as toothbrushes or razors with somebody already hep C positive, receiving tattoos or piercings in unregulated settings, and even through medical procedures in environments with inadequate infection control.”
Another common misconception is confusing hep C with hep B. Hep B and hep C are caused by different viruses and have distinct modes of transmission, though they share the blood-to-blood component as well as some symptoms. Hep B is preventable through vaccination, whereas hep C does not yet have a vaccine but is curable with appropriate medical intervention.
This skeleton in the cupboard further complicates efforts to educate and screen individuals at risk. This stigma can prevent people from seeking testing or treatment, perpetuating the virus’ spread unknowingly. “Education is key to dispelling stigma,” emphasizes Christine. “ By understanding how hep C spreads and who is at risk, individuals can make informed decisions about their health and take proactive steps towards prevention and treatment.”
Furthermore, there’s a misconception that only certain demographics or socio-economic groups are vulnerable to hep C. In reality, anyone can contract hep C, regardless of their background or lifestyle. Healthcare workers, including nurses and first responders, are also at risk due to potential exposure to infected blood.
But what exactly is hepatitis C? It is a type of blood-borne virus that targets the liver, causing inflammation and liver damage if untreated, and is the leading cause of liver cancer. It spreads between people by blood-to-blood contact. Prior to its discovery in 1989, hepatitis C infection occurred primarily because patients received treatment products made with blood from people who had the virus.
Effective education about hep C not only clarifies misconceptions but also encourages individuals to get tested. Early detection is crucial as it allows for timely treatment, which can prevent liver damage and reduce the risk of transmission to others. Despite its potentially severe consequences, hep C often presents with mild or no symptoms for many years, underscoring the importance of routine testing, especially for at-risk populations.
“In our outreach efforts, we’ve encountered numerous instances where individuals declined testing because they felt hep C was not relevant to them,” shares Ms. Sewell. “This underscores the urgent need for widespread education campaigns that emphasize the diversity of risk factors and the importance of regular screenings.” Even the CDC recommends that anyone over 18 should be tested at least once regardless of perceived risk factors.
The economic climate further complicates access to healthcare. Though hep C treatment no longer requires a specialist, the biggest hurdle to eliminating hepatitis C is the lack of access to affordable healthcare to treat the disease, especially for those in underserved populations. Even when referrals are possible, they require follow-up visits that patients may miss and co-payments they may be unable to afford. Programs like PALS (Patient Assistance for Lab Services) play a crucial role in providing affordable testing options to those in need, regardless of their insurance status.
“Access to affordable testing is a fundamental right,” Christine asserts. “By partnering with healthcare providers and community organizations, we aim to expand access to hep C testing and ensure that cost is not a barrier to diagnosis and treatment.”
In 2016, the World Health Organization (WHO) declared eliminating Hepatitis C as a public health threat by 2030 – a goal that hinges on widespread education, increased testing, and improved access to treatment. Achieving this goal requires collaborative efforts from healthcare providers, policymakers, and the community at large to raise awareness, reduce stigma, increase funding for programs, such as Hep C Alliance, and ensure equitable access to care.
As humans navigate toward a future where Hepatitis C is no longer a threat, education remains the most powerful weapon. By debunking myths, promoting accurate information, and advocating for accessible healthcare, individuals can be empowered to take charge of their health and contribute to a hep C-free world.